# The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity

> **NCT02689999** · PHASE4 · COMPLETED · sponsor: **Neutec Ar-Ge San ve Tic A.Ş** · enrollment: 12 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease (GERD)

## Interventions

- **DRUG:** Dexrabeprazole 10 mg Enteric-Coated Tablets

## Key facts

- **NCT ID:** NCT02689999
- **Lead sponsor:** Neutec Ar-Ge San ve Tic A.Ş
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-05
- **Final completion:** 2017-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02689999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02689999, "The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02689999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*